心肌缺血再灌注损伤防治研究进展

被引:7
作者
杜蕾
蒋金法
机构
[1] 同济大学附属同济医院心内科
[2] 同济大学附属同济医院心内科 上海
[3] 上海
关键词
心肌缺血; 再灌注损伤; 防治;
D O I
暂无
中图分类号
R542.22 [];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:286 / 288
页数:3
相关论文
共 19 条
[1]  
Cardioprotection from ischemia and reperfusion injury by an endothelin A-receptor antagonist in relation to nitric oxide production. Gonon AT,Gourine AV,Pernow J. Journal of Cardiovascular Pharmacology . 2000
[2]  
Angiotensin II type 1a receptor is involved in the occurrence of reperfusion arrhythmias. Harada K,Komuro I,Hayashi D,et al. Circulation . 1998
[3]  
Effects of different steroid treatment on reperfusion-associated production of reactive oxygen species and arrhythmias during coronary surgery. Volk T,Schmutzler M,Engelhardt L,et al. Acta Anaesthesiologica . 2003
[4]  
Neuroprotective effects of copper/zinc-dependent superoxide dismutase against a wide variety of death-inducing stimuli and proapoptotic effect of familial amyotrophic lateral sclerosis mutations. Patel Y,Collaco Moraes Y,Latchman D,et al. Brain Research Molecular Brain Research . 2002
[5]  
Blockade of platelet endothelial cell adhesion molecule-1 protects against myocardial ischemia and reperfusion injury in cats. Murohara T,Delyani JA,Albelda SM,et al. J Immunol . 1996
[6]  
Enhanced reduction of myocardial infarct size by combined ACE inhibition and AT(1)-receptor antagonism. Weidenbach R,Schulz R,Gres P,et al. British Journal of Pharmacology . 2000
[7]  
Mechanisms of myocardial reperfusion injury. Park JL,Lucchesi BR. The Annals of Thoracic Surgery . 1999
[8]  
The myocardial Na+/H+ exchanger:a potential therapeutic target for the prevention of myocardial ischaemic and reperfusion injury and attenuation of postinfarction heart failure. Karmazyn M,Sostaric JV,Gan XT. Drugs . 2001
[9]  
The role of endothelin, protein kinase C and free radicals in the mechanism of the post-ischemic endothelial dysfunction in guinea-pig hearts. Maczewski M,Beresewicz A. Journal of Molecular and Cellular Cardiology . 2000
[10]  
IRFI 042, a novel dual vitamin Elike antioxidant, inhibits activation of nuclear factor-kappaB and reduces the inflammatory response in myocardial ischemia-reperfusion injury. Altavilla D,Deodato B,Campo GM,et al. Cardiovascular Research . 2000